Clinical Trials Logo

Pregnancy in Diabetics clinical trials

View clinical trials related to Pregnancy in Diabetics.

Filter by:

NCT ID: NCT04292509 Completed - Clinical trials for Pregnant Women With Type 1 Diabetes

Risk for Ketonaemia in Type 1 Diabetes Pregnancies With Sensor-augmented Pump Therapy

ROKSANA
Start date: February 15, 2020
Phase: N/A
Study type: Interventional

The ROKSANA study is an open-label crossover RCT with the aim to evaluate whether sensor-augmented pump therapy (SAP) with predictive low glucose suspend technology is associated with an increased risk for ketonaemia during type 1 diabetes pregnancies.

NCT ID: NCT04273412 Completed - Clinical trials for Gestational Diabetes Mellitus in Pregnancy

Lifestyle Intervention for Prevention of Gestational Diabetes Mellitus in the UAE Population

Start date: October 13, 2018
Phase: N/A
Study type: Interventional

Gestational diabetes mellitus (GDM) is a high blood glucose (hyperglycemia) first occurring or first recognized during pregnancy, it is affecting 16.4% of women globally and 36.6 % in this region. It is consistent, strong evidence on the impact of GDM on short and long term health impacts on both mother and her child, thereby presenting significant challenges to acute care and public health. Currently, our understanding of strategies that are effective in preventing GDM is limited. Indeed, prospective studies have indicated a positive result of lifestyle intervention on preventing the risk of GDM in pregnant women but we lack consistency in the findings from randomized controlled trials (RCT). Moreover, most of these trials have been reported from developed countries and none of them were presented from this region. In the present project, we aim to determine whether GDM can be prevented by a 12-week moderate lifestyle intervention compared with usual standard care in high-risk pregnant women. In addition, we will also examine maternal pregnancy and birth outcomes.

NCT ID: NCT04101396 Completed - Clinical trials for Gestational Diabetes Mellitus in Pregnancy

4 vs 7 Points Blood Glucose Monitoring in Gestational Diabetes on Dietary Modification

Start date: October 25, 2019
Phase: N/A
Study type: Interventional

This study aims to compare between 4 and 7 points blood glucose monitoring in women with gestational diabetes on diet modification.

NCT ID: NCT04054843 Completed - Clinical trials for Gestational Diabetes Mellitus in Pregnancy

Afamin in Gestational Diabetes Mellitus

Start date: September 1, 2019
Phase:
Study type: Observational

This study includes pregnancies in 11 to 14 th gestational weeks. Investigators will sample maternal plasma in the first trimester and analyze maternal plasma afamin values. All these women will then be screened by two step OGTT. Investigators will compare afamin levels in GDM and control groups.

NCT ID: NCT04009889 Completed - Clinical trials for Gestational Diabetes Mellitus in Pregnancy

Impact of Oral Probiotic Blend on Pregnancy Outcome

Start date: April 5, 2018
Phase: N/A
Study type: Interventional

The aim of this study is, to investigate the effect of oral intake of Lactobacillus rhamnosus GG (ATCC 53103), Lactobacillus crispatus Lbv88, Lactobacillus rhamnosus Lbv96, Lactobacillus jensenii Lbv116 Lactobacillus gasseri Lbv150 on outcomes of pregnancy and microbiota and their interrelation.

NCT ID: NCT03961542 Completed - Clinical trials for Gestational Diabetes Mellitus in Pregnancy

Effects of Chewing Gum on Glycaemic Control in Women With Gestational Diabetes

Start date: December 22, 2017
Phase: N/A
Study type: Interventional

This study aims to assess the impact of enhanced chewing on glycaemic control in females with newly diagnosed GDM. It is hypothesised, that a fixed amount of gum chewed for 20 minutes before starting each meal could improve hyperglycaemia. The impact of chewing on postprandial capillary blood glucose (measured at one hour after breakfast, lunch and dinner) is determined as the primary outcome of this study. Differences in fasting glucose and longitudinal changes over the study period should be additionally examined.

NCT ID: NCT03925064 Completed - Clinical trials for Gestational Diabetes

Fetal Myocardial Performance Index in Diabetic Pregnancies

Start date: August 1, 2018
Phase:
Study type: Observational

The myocardial tissue is the most likely structure affected by hyperglycemia. The myocardial performance index (MPI) is a pulsed wave Doppler-derived index of global myocardial function. It is defined as the sum of the isovolumetric contraction time (ICT) and isovolumetric relaxation time (IRT) divided by the ejection time (ET) The fetal right heart contributes more to the cardiac output than the left heart; therefore, it is important to assess the right ventricular function. The investigators will measure right ventricular MPI in diabetic and normal pregnancies.

NCT ID: NCT03922087 Completed - Obesity Clinical Trials

No-worry Baby Project

Start date: November 20, 2018
Phase:
Study type: Observational

The Huizhou mother-infant cohort was set up to investigate the effect of dietary factors and environmental exposures during pregnancy on health consequences of mothers and offsprings in Huizhou, China.

NCT ID: NCT03881956 Completed - Clinical trials for Gestational Diabetes Mellitus in Pregnancy

Health-promoting Lifestyle Education on Women With Gestational Diabetes Mellitus

Start date: January 1, 2015
Phase: N/A
Study type: Interventional

In this study the effect of the Health-Promoting Lifestyle Education Program (HPLEP) provided to women with GDM on maternal and neonatal health was investigated. The education program and also usual care applied to the intervention group, only usual care applied to the control group.

NCT ID: NCT03838380 Completed - Clinical trials for Gestational Diabetes Mellitus in Pregnancy

Smartphone Application for the Management of Gestational Diabetes Mellitus

Start date: February 1, 2017
Phase: N/A
Study type: Interventional

The prevalence of gestational diabetes mellitus (GDM) has been progressively increasing. It is important to recognize and treat GDM to minimize the risk of maternal and neonatal complications. Multifaceted professional interventions are effective in the management of GDM and mobile healthcare can be an effective approach. The purpose of the current study was to develop and evaluate a model for prevention and management of GDM using mobile healthcare. Subjects with no previous history of diabetes, who were diagnosed with GDM during 24-28 weeks of gestation, were randomly divided into a conventional management group and a mobile management group. The conventional mangement group received conventional GDM management and could freely use the mobile healthcare application. The mobile management group received mobile healthcare services including tailored mobile coaching. The effectiveness of the management using the application were evaluated through the result values of the laboratory tests, anthropometric measurement performed during the study period and perinatal outcomes.